World's Best Scientists 2026 revealed!
Shibo Jiang

Shibo Jiang

Award Badge
Immunology
China
2023

D-Index & Metrics

Medicine

D-Index
115
Citations
50126
World Ranking
4530
National Ranking
42

Research.com Recognitions

  • 2023 - Research.com Immunology in China Leader Award
  • 2022 - Research.com Immunology in China Leader Award

Overview

Shibo Jiang is affiliated with Fudan University in China and has contributed extensively to research in the field of medicine, with a specific focus on infectious diseases. Their body of work encompasses related subfields such as animal science and zoology, epidemiology, molecular biology, and immunology.

Their research topics prominently feature SARS-CoV-2 and COVID-19 research, including clinical studies and detection methods. Other notable topics include animal virus infections, viral gastroenteritis research, HIV research and treatment, and drug development for HIV/AIDS.

Frequent co-authors include Lu Lu, Wei Xu, Shuai Xia, Qian Wang, and Zezhong Liu, reflecting a collaborative research environment across multiple studies.

Shibo Jiang has published in several key venues, with multiple contributions to:

  • Signal Transduction and Targeted Therapy
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Medical Virology
  • Cell Research
  • Viruses

Selected recent papers demonstrate a focus on coronavirus biology, viral inhibition, and antibody development:

  • Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine, 2020, Cellular and Molecular Immunology
  • Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, 2020, Cell Research
  • Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody, 2020, Emerging Microbes & Infections
  • Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses, 2020, Trends in Immunology
  • Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy, 2020, Science

The scientist has also contributed to book publications, including a title released by Springer Nature:

  • Virus Entry Inhibitors, 2022

Best Publications

  • The spike protein of SARS-CoV — a target for vaccine and therapeutic development

    Lanying Du;Yuxian He;Yusen Zhou;Shuwen Liu

  • Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine.

    Wanbo Tai;Lei He;Xiujuan Zhang;Jing Pu;Jing Pu

  • Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.

    Shuai Xia;Meiqin Liu;Chao Wang;Wei Xu

  • Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody.

    Xiaolong Tian;Cheng Li;Ailing Huang;Shuai Xia

  • Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways.

    Yanqing Ding;Li He;Qingling Zhang;Zhongxi Huang

  • Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses.

    Shibo Jiang;Shibo Jiang;Christopher Hillyer;Lanying Du

  • Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy.

    Hongjing Gu;Qi Chen;Guan Yang;Lei He

  • Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein.

    Shuai Xia;Yun Zhu;Meiqin Liu;Qiaoshuai Lan

  • Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications

    Fan Wu;Aojie Wang;Mei Liu;Qimin Wang

  • Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors.

    Shuwen Liu;Gengfu Xiao;Yibang Chen;Yuxian He

  • HIV-1 inhibition by a peptide

    Shibo Jiang;Kang Lin;N. Strick;A. R. Neurath

  • Recent advances in the detection of respiratory virus infection in humans

    Naru Zhang;Lili Wang;Xiaoqian Deng;Ruiying Liang

  • Retraction Note to: SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion.

    Xinling Wang;Wei Xu;Gaowei Hu;Shuai Xia

  • A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike

    Shuai Xia;Lei Yan;Wei Xu;Anurodh Shankar Agrawal

  • Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor

    Lu Lu;Qi. Liu;Yun Zhu;Kwok-Hung Chan

  • Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS.

    L He;Y Ding;Q Zhang;X Che

  • AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells.

    Shuai Wang;Zongyang Qiu;Zongyang Qiu;Yingnan Hou;Yingnan Hou;Xiya Deng;Xiya Deng

  • Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine.

    Yuxian He;Yusen Zhou;Shuwen Liu;Zhihua Kou

  • Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China.

    Fei Yu;Lanying Du;David M. Ojcius;Chungen Pan

  • Quercetin as an Antiviral Agent Inhibits Influenza A Virus (IAV) Entry

    Wenjiao Wu;Richan Li;Xianglian Li;Jian He

Frequent Co-Authors

Lu Lu
Lu Lu Fudan University
Lanying Du
Lanying Du Georgia State University
Shuwen Liu
Shuwen Liu Southern Medical University
Yusen Zhou
Yusen Zhou Zhengzhou University
Yuxian He
Yuxian He Peking Union Medical College Hospital
Tianlei Ying
Tianlei Ying Fudan University
Bo-Jian Zheng
Bo-Jian Zheng University of Hong Kong
Chien Te K. Tseng
Chien Te K. Tseng The University of Texas Medical Branch at Galveston
Dimiter S. Dimitrov
Dimiter S. Dimitrov University of Pittsburgh
Sara Lustigman
Sara Lustigman New York Blood Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Medicine in the USA opens doors to diverse healthcare career options—many of which can be accessed or enhanced through specialized online degrees. For those interested in healthcare leadership or administration, exploring cheapest mha programs online is a practical way to gain management skills while keeping tuition affordable.

Nurses seeking advanced practice roles can consider the most affordable online dnp programs, which allow RNs to earn a Doctor of Nursing Practice and meet the high demand for skilled practitioners without interrupting their current careers.

Those fascinated by pharmaceuticals can investigate online pharmacy school cost to discover accessible routes to becoming a Doctor of Pharmacy (PharmD) through flexible, lower-cost online options.

Finally, if managing patient records and health data appeals to you, an online mhi (Master of Health Information Management) program can position you at the intersection of healthcare and technology.

Online degrees offer flexibility, affordability, and a tailored career pathway for those aspiring to excel in many medical and healthcare roles beyond traditional MD programs.

Best Scientists Citing Shibo Jiang

Trending Scientists